Skip to content

Yukio Ago

3 papers in the library · 91 citations · publishing 2019-2026

Papers

Sort Most recent Most cited

286. Restoration by ketamine metabolites of cognitive and affective prosocial behaviors in a mouse model of depression

The International Journal of Neuropsychopharmacology September 9, 2026 Rei Yokoyama, M Matsumi, S Asano et al.

Abstract Background The execution of prosocial behaviors requires the ability to accurately understand and infer others’ affective states. Impairments in prosocial functioning have been shown to be associated with the pathology of several psychiatric disorders. In particular, individuals with depression exhibit reduced cognitive and affective responses to others’ emotions. These impairments may...

THE NEURONAL CIRCUITS IMPLICATED IN THE PHENCYCLIDINE-INDUCED BEHAVIORAL IMPAIRMENTS AND THERAPEUTIC AND SIDE EFFECTS OF ARIPIPRAZOLE

The International Journal of Neuropsychopharmacology February 1, 2025 *Ami Ono, D. Koan, S. Asano et al.

Abstract Background Schizophrenia is a psychiatric disorder characterized by positive and negative symptoms and cognitive impairments. Second-and third-generation antipsychotics alleviate not only positive symptoms but also negative symptoms and cognitive impairments, with a lower liability for extrapyramidal symptoms (EPS).Accumulating evidences suggest that dopaminergic mesocorticolimbic and...

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism

The International Journal of Neuropsychopharmacology July 16, 2019 Yukio Ago, Wataru Tanabe, Momoko Higuchi et al. 91 citations

BACKGROUND: Although recent studies provide insight into the molecular mechanisms of the effects of ketamine, the antidepressant mechanism of ketamine enantiomers and their metabolites is not fully understood. In view of the involvement of mechanisms other than the N-methyl-D-aspartate receptor in ketamine's action, we investigated the effects of (R)-ketamine, (S)-ketamine, (R)-norketamine...